|
ATCC
s aureus mu50 ![]() S Aureus Mu50, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/s aureus mu50/product/ATCC Average 99 stars, based on 1 article reviews
s aureus mu50 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
7 cyano 7 deazaguanine reductase ![]() 7 Cyano 7 Deazaguanine Reductase, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/7 cyano 7 deazaguanine reductase/product/ATCC Average 96 stars, based on 1 article reviews
7 cyano 7 deazaguanine reductase - by Bioz Stars,
2026-03
96/100 stars
|
Buy from Supplier |
|
ATCC
mu50 ![]() Mu50, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mu50/product/ATCC Average 99 stars, based on 1 article reviews
mu50 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
common s aureus subtypes ![]() Common S Aureus Subtypes, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/common s aureus subtypes/product/ATCC Average 96 stars, based on 1 article reviews
common s aureus subtypes - by Bioz Stars,
2026-03
96/100 stars
|
Buy from Supplier |
|
ATCC
2025 synergy mssa atcc25923 mrsa mu50 ![]() 2025 Synergy Mssa Atcc25923 Mrsa Mu50, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/2025 synergy mssa atcc25923 mrsa mu50/product/ATCC Average 99 stars, based on 1 article reviews
2025 synergy mssa atcc25923 mrsa mu50 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
staphylococcus aureus mu50 6 9 ![]() Staphylococcus Aureus Mu50 6 9, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/staphylococcus aureus mu50 6 9/product/ATCC Average 99 stars, based on 1 article reviews
staphylococcus aureus mu50 6 9 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
ATCC
staphylococcus aureus mu50 ![]() Staphylococcus Aureus Mu50, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/staphylococcus aureus mu50/product/ATCC Average 99 stars, based on 1 article reviews
staphylococcus aureus mu50 - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Strain-dependent ear swelling responses of clinical isolates upon topical application. ( a ) Experimental protocol: nonclinical S. aureus strains Mu3 and Mu50, AD patient–derived S. aureus and S. epidermidis strains (AD1–AD4), and TSB as a control vehicle were topically applied to the ears of C57BL/6 mice on days 0, 2, 4, 6, and 8. Clinical skin inflammation was assessed by measuring ear thickness. ( b ) Ear swelling over time: mean ear thickness (μm) from day 0 (denoted as D0) to day 9 (denoted as D9) for each treatment group (n = 6–8 mice per group). ( c ) Cumulative ear swelling: individual values and group mean ± SEM for the AUC of ear thickness measurements from D0 to D9 (n = 6–8 mice per group). Statistical analysis: 1-way ANOVA followed by Tukey’s multiple comparisons test. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. Symbols indicate statistical significance compared with the following groups: § vehicle, $ S. aureus Mu3, + S. aureus Mu50, @ S. aureus AD3, ∗ S. epidermidis AD3, and ° S. epidermidis AD4. AUC, area under the curve; TSB, tryptic soy broth.
Article Snippet: Two nonclinical reference strains— S. aureus Mu3 (ATCC 700698) and
Techniques: Derivative Assay, Control
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Histological analysis of mouse ear skin after treatment with bacterial strains. ( a ) Representative images: H&E-stained sections of mouse ear skin collected on day 9 after treatment with S. aureus (Mu3, Mu50, AD1–AD4), S. epidermidis (AD-derived strains), or TSB. Bar = 50 μm. ( b ) Epidermal thickness: mean epidermal thickness (μm) ± SEM from H&E-stained sections (n = 6–8 mice per group). ( c ) Dermal cellular infiltration: mean dermal cell infiltration ± SEM from the same histological images (n = 5–8 mice per group). Statistical analysis: Kruskal–Wallis test followed by Dunn’s multiple comparisons test. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. Symbols indicate statistical significance compared with the following groups: § vehicle, $ S. aureus Mu3, + S. aureus Mu50, @ S. aureus AD3, ∗ S. epidermidis AD3, and ° S. epidermidis AD4. AD, atopic dermatitis; TSB, tryptic soy broth.
Article Snippet: Two nonclinical reference strains— S. aureus Mu3 (ATCC 700698) and
Techniques: Staining, Derivative Assay
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Distribution of virulence genes across S. aureus strains. Virulence gene content of 6 S. aureus strains (Mu3, Mu50, AD1, AD2, AD3, and AD4) was analyzed by microarray and grouped by functional categories. Bars represent the number of genes identified within each category per strain. Categories include adhesion factors, staphylococcal superantigen/enterotoxin-like genes, HLG and leukocidins, enterotoxins, proteases, capsule- and biofilm-associated genes, hemolysins, HLb-converting phages, defensin resistance, toxic shock toxin, ACME locus, and other factors. The plot illustrates variation in virulence gene repertoire between strains, with adhesion factors and enterotoxin-like genes showing the highest representation. ACME, arginine catabolic mobile element; HLG, hemolysin .
Article Snippet: Two nonclinical reference strains— S. aureus Mu3 (ATCC 700698) and
Techniques: Microarray, Functional Assay
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Comparative genomic presence of virulence- and regulation-associated gene families in S. aureus Strains. Heatmaps depict the distribution of gene families associated with ( a ) regulation, ( b ) superantigen-like proteins, ( c ) adhesion, ( d ) biofilm formation, ( e ) leukocidins, ( f ) unconventional virulence factors, and ( g ) proteases across 7 S. aureus strains (MRSA USA300, Mu3, Mu50, AD1, AD2, AD3, and AD 4). Each cell represents the status of a gene in a given strain: presence (yellow), absence (purple), or ambiguous (gray). MRSA, Methicillin-Resistant Staphylococcus aureus .
Article Snippet: Two nonclinical reference strains— S. aureus Mu3 (ATCC 700698) and
Techniques:
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Strain-dependent ear swelling responses of clinical isolates upon topical application. ( a ) Experimental protocol: nonclinical S. aureus strains Mu3 and Mu50, AD patient–derived S. aureus and S. epidermidis strains (AD1–AD4), and TSB as a control vehicle were topically applied to the ears of C57BL/6 mice on days 0, 2, 4, 6, and 8. Clinical skin inflammation was assessed by measuring ear thickness. ( b ) Ear swelling over time: mean ear thickness (μm) from day 0 (denoted as D0) to day 9 (denoted as D9) for each treatment group (n = 6–8 mice per group). ( c ) Cumulative ear swelling: individual values and group mean ± SEM for the AUC of ear thickness measurements from D0 to D9 (n = 6–8 mice per group). Statistical analysis: 1-way ANOVA followed by Tukey’s multiple comparisons test. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. Symbols indicate statistical significance compared with the following groups: § vehicle, $ S. aureus Mu3, + S. aureus Mu50, @ S. aureus AD3, ∗ S. epidermidis AD3, and ° S. epidermidis AD4. AUC, area under the curve; TSB, tryptic soy broth.
Article Snippet: We also included S. aureus strains Mu3 (ATCC 700698) and
Techniques: Derivative Assay, Control
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Histological analysis of mouse ear skin after treatment with bacterial strains. ( a ) Representative images: H&E-stained sections of mouse ear skin collected on day 9 after treatment with S. aureus (Mu3, Mu50, AD1–AD4), S. epidermidis (AD-derived strains), or TSB. Bar = 50 μm. ( b ) Epidermal thickness: mean epidermal thickness (μm) ± SEM from H&E-stained sections (n = 6–8 mice per group). ( c ) Dermal cellular infiltration: mean dermal cell infiltration ± SEM from the same histological images (n = 5–8 mice per group). Statistical analysis: Kruskal–Wallis test followed by Dunn’s multiple comparisons test. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. Symbols indicate statistical significance compared with the following groups: § vehicle, $ S. aureus Mu3, + S. aureus Mu50, @ S. aureus AD3, ∗ S. epidermidis AD3, and ° S. epidermidis AD4. AD, atopic dermatitis; TSB, tryptic soy broth.
Article Snippet: We also included S. aureus strains Mu3 (ATCC 700698) and
Techniques: Staining, Derivative Assay
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Distribution of virulence genes across S. aureus strains. Virulence gene content of 6 S. aureus strains (Mu3, Mu50, AD1, AD2, AD3, and AD4) was analyzed by microarray and grouped by functional categories. Bars represent the number of genes identified within each category per strain. Categories include adhesion factors, staphylococcal superantigen/enterotoxin-like genes, HLG and leukocidins, enterotoxins, proteases, capsule- and biofilm-associated genes, hemolysins, HLb-converting phages, defensin resistance, toxic shock toxin, ACME locus, and other factors. The plot illustrates variation in virulence gene repertoire between strains, with adhesion factors and enterotoxin-like genes showing the highest representation. ACME, arginine catabolic mobile element; HLG, hemolysin .
Article Snippet: We also included S. aureus strains Mu3 (ATCC 700698) and
Techniques: Microarray, Functional Assay
Journal: JID Innovations
Article Title: Atopic Dermatitis–like mouse model using early inoculation of patient-derived S. aureus together with MC903
doi: 10.1016/j.xjidi.2025.100436
Figure Lengend Snippet: Comparative genomic presence of virulence- and regulation-associated gene families in S. aureus Strains. Heatmaps depict the distribution of gene families associated with ( a ) regulation, ( b ) superantigen-like proteins, ( c ) adhesion, ( d ) biofilm formation, ( e ) leukocidins, ( f ) unconventional virulence factors, and ( g ) proteases across 7 S. aureus strains (MRSA USA300, Mu3, Mu50, AD1, AD2, AD3, and AD 4). Each cell represents the status of a gene in a given strain: presence (yellow), absence (purple), or ambiguous (gray). MRSA, Methicillin-Resistant Staphylococcus aureus .
Article Snippet: We also included S. aureus strains Mu3 (ATCC 700698) and
Techniques: